Material
The cytokine IL-15 and the inhibitor of DNA binding (Id)2, which negatively regulates the activity of basic helix-loop-helix transcription factors, have been shown to play key roles in NK cell development. Consistent with this, exogenous IL-15 added to human thymic progenitor cells stimulated their development into NK cells at the expense of T cells both in fetal thymic organ culture and in coculture with stromal cells expressing the Notch ligand Delta-like 1. Overexpression of Id2 in thymic progenitor cells stimulated NK cell development and blocked T cell development. This, in part, is attributed to inhibition of the transcriptional activity of the E protein HEB, which we show in this study is the only E protein that enhanced T cell development. Notably, Id2 increased a pool of lineage CD1a -
CD5
+ progenitor cells that in synergy with IL-15 furthered expansion and differentiation into NK cells. Taken together, our findings point to a dualistic function of Id2 in controlling T/NK cell lineage decisions; T cell development is impaired by Id2, most likely by sequestering HEB, whereas NK cell development is promoted by increasing a pool of CD1a It is therefore not surprising that T and NK cells originate from a common precursor. Bipotential T/NK precursor cells have been found in the thymus of both humans (1) and mice (2, 3) . Yet the thymus produces predominantly T cells and relatively very few NK cells, suggesting that the thymus microenvironment favors the development of T cells over NK cells. Although early cellular stages in T cell development have been defined reasonably well, the early stages of thymic NK cell development and the mechanisms regulating these steps remain poorly understood. Freud et al. (4) described the characterization of the different stages of NK cell differentiation in human secondary lymphoid organs, whereas Sanchez et al. (5) identified several stages of committed and uncommitted NK cell precursors in the thymus. In the human thymus CD34 + CD1a -, cells mark an uncommitted stage in development, which can be subdivided in an early CD5 -and a later CD5 + stage (6, 7) . Both the CD34 + CD1a -CD5 -and CD34 + CD1a -CD5 + precursor cells have T cell as well as NK cell potential. Upregulation of the cell surface marker CD1a on CD34 + progenitor cells is strongly, but not absolutely, associated with commitment to the T cell lineage (8) as the CD1a + CD5 + subset still has little NK cell, but no conventional or plasmacytoid dendritic cell (pDC) precursor activity (8, 9) .
It has been well established that E proteins, which are members of the basic helix-loop-helix (bHLH) family of transcription factors, play crucial roles in development of T cells, B cells, and pDCs (6, 10) . Members of the bHLH family are characterized by two conserved domains, a HLH domain mediating homo-and/or heterodimerization and a basic domain allowing DNA binding of the protein dimers. Four E proteins, including E12, E47, HEB, and E2-2, have been identified (11) . Mice deficient for the E2A splice variants E12 and E47 lack B cells and exhibit disturbed T cell development (12) . In addition, T cell development is compromised in mice lacking E2-2 or HEB (13, 14) . The transcriptional activities of E proteins are controlled by inhibitor of DNA binding (Id) proteins. Id factors also contain a HLH domain, allowing dimerization with E proteins. However, Id proteins lack the basic DNAbinding domain and as a consequence complexes of E and Id proteins are transcriptionally inactive. In line with impaired T cell development in E protein knock-out mice we have reported that the forced expression of Id3 in human progenitor cells inhibits their development into T cells and at the same time promotes NK cell development (7, 15) . These findings are consistent with the observation that the number of NK cell precursors (NKPs) is severely reduced in mice deficient for the Id3-related protein Id2 (16, 17) . However, a more extensive analysis revealed that the number of NK precursors was not affected by Id2 deletion, but that development of these precursors into mature NK cells was blocked (18) . No gross defects on lymphoid development were reported in Id3-deficient mice (19) . Therefore, it is conceivable that Id2 is the physiological factor for NK cell development, not only in mice but also in humans. The role of Id2 on human NK cell development, however, has not been examined.
The cytokine IL-15 has been shown to play an important role in NK cell development. SCID patients who have a defect in IL-15 signaling have impaired NK cell development (20) . Consistent with this, human NK cell development in an in vivo humanized mouse model is strongly augmented when recombinant IL-15/IL-15Ra-Fc complexes were injected (21) . Similarly, mouse NK cell development depends on IL-15 as mice deficient for IL-15 (22) or components of the IL-15R complex (23) have strongly reduced numbers of NK cells. In addition, murine progenitor cells cultured in fetal thymic organ culture (FTOC) with high concentrations of IL-15 are potently blocked in their TCR-ab + T cell development and instead differentiate into NK cells (24) . Recently, it was shown that the generation of NKPs does not depend on IL-15 signaling as common g chain (g c )-deficient mice have normal numbers of NKPs (25) . However, this leaves unresolved whether IL-15 affects NK cell development at the progenitor stage by inducing differentiation or by stimulating survival and/or expansion at the mature NK cell stage.
In this study, we provide evidence that Id2 is as potent as Id3 in blocking human T cell development and stimulating NK cell development in FTOC or in a coculture system using OP9 stromal cells expressing the Notch ligand Delta-like 1 (OP9-DL1). Thymic progenitor cells ectopically expressing Id2 gave rise to increased numbers of CD1a -CD5 + early progenitor cells, that with IL-15 further expanded and differentiated into mature NK cells. The Id2-induced progenitor cell expansion could be counteracted by coexpression of HEB. This, together with the finding that HEB is the only bHLH factor that stimulated T cell development, suggests that the balance between Id2 and HEB regulates the T/NK cell bifurcation: high levels of HEB promote T and inhibit NK cell development, whereas high Id2 levels block T cell development and prepare a pool of IL-15 responsive NK cell progenitor cells. MAbs to CD1a, CD3, CD4, CD5, CD7, CD8, CD16, CD56, CD94, CD122,  CD127, NKG2D, NKP30, NKP46 , conjugated to PE, PerCP, PeCy7, APC, or APCCy7 were purchased from Becton Dickinson (BD Biosciences, San Jose, CA) or Biolegend (San Diego, CA). CD1a-PE and CD56-APC were obtained from Beckman Coulter (Marseille, France). The human cytokines IL-15 and stem cell factor were obtained from R&D Systems (Abingdon, U.K.). IL-7 and FLT3L were a kind gift from Dr. J. Cornelissen (Erasmus University, Rotterdam, The Netherlands).
Materials and Methods

MAbs and cytokines
Cell lines, constructs, and retrovirus production
The naive OP9 murine stromal cell line was kindly provided by Dr. T. Nakano (Osaka University, Osaka, Japan). The OP9-DL1/neo cell line was previously established (26) . Human cDNA sequences for Id2, Id3, E2-2 (10), Id2DHLH (27) , HEB [obtained from Dr. D. Littman, New York University School of Medicine, New York, NY (28)], E12, and E47 (both obtained from Dr. C. Murre, University of California at San Diego, La Jolla, CA) were ligated into the retroviral vector LZRS-internal ribosome entry site (IRES)-GPF or LZRS-IRES-yellow fluorescent protein (YFP) (26) . The empty constructs were used in control transductions. Retroviral supernatants were obtained from transfected Phoenix-GALV packaging cells (29) .
Isolation of CD34
+ cells from postnatal thymus 
Retroviral transduction and differentiation assays
For transduction experiments, CD34 +
CD1a
-postnatal thymocytes were cultured overnight in Yssel's medium (30) with 5% hormal human serum, 20 ng/ml stem cell factor, and 10 ng/ml IL-7. The following day cells were incubated for 6-7 h with virus supernatant in retronectin-coated plates (30 mg/ml; Takara Biomedicals, Shiga, Japan).
The development of T and NK cells was assessed by coculturing the mixture of transduced and nontransduced CD34 +
-progenitor cells in the hybrid murine/human FTOC as has been described previously (31) . IL-15 was added at the onset of the culture, the medium containing IL-15 was refreshed every week.
Alternatively the mixture of transduced and nontransduced CD34 
STAT5 phosphorylation
The CD1a 
RT-PCR
Results
IL-15 stimulates NK cell and inhibits T cell development
A role for IL-15 in mouse and human NK cell development is well documented (4, 21-23, 25, 32, 33) . In mice, IL-15 blocks T cell development (24) , suggesting that IL-15 can alter the developmental potential of bipotential T/NK cell precursors. In this study, we investigated the role of IL-15 in the T/NK cell diversification in human. The data in Similar results were obtained when thymic progenitor cells were cultured on OP9 stromal cells expressing the OP9-DL1, which have been shown to support T cell development in vitro in the presence of IL-7 and FLT3L (26) . Increasing the dose of IL-15 to 10 ng/ml blocked T cell development, as a 20-fold reduction in absolute CD56 -CD3 + T cell numbers was observed compared with the condition in which no IL-15 was added (Fig. 1B) . Concurrently, 10-fold reduced numbers of CD4 + CD8
+ DP T cells were recovered in the presence of the highest dose of IL-15 tested (10 ng/ml) when compared with the condition in which no IL-15 was added. In contrast, the absolute numbers of CD3 -CD56
+ NK cells increased up to 100-fold in the presence of 10 ng/ml IL-15 compared with cultures without IL-15 (Fig. 1B) . These data add further support to the notion that IL-15 stimulates NK cell development at the expense of T cell development.
Id2 inhibits T cell development and stimulates NK cell development similar to Id3
In addition to IL-15, it is known that the balance of Id and E proteins plays an important role in the T/NK lineage decision. Consistent with a role for Id proteins in this lineage decision, Id2
mice have impaired NK cell development (17) . In addition, we previously observed that Id3 promotes human NK cell development in FTOC (15) . However, because no gross defects in lymphoid development were reported in Id3-deficient mice (19) , it is more likely to assume that Id2 is the physiological factor involved in NK cell development. To obtain further insight in the role of Id2 as the central factor involved in human NK cell development, we determined mRNA expression levels of Id2 and Id3 in freshly isolated human thymic NK cells. Using real-time RT-PCR we observed that mature thymic NK cells expressed Id2 at 35-fold higher levels and Id3 at 3-fold higher levels compared with expression levels in thymic CD34 + CD1a -progenitor cells ( Fig. 2A) . This supports the notion that high Id levels, in particular Id2, may be favorable for human NK cell development.
To determine whether Id2 inhibits human T cell development in a manner similar to Id3, we overexpressed Id2 by retroviral gene transfer in CD34 + CD1a -thymic precursor cells and cultured the cells in FTOC (Fig. 2B) . Ectopic expression of Id2 in CD34 + CD1a -thymic precursors inhibited their ability to develop into T cells, as reduced percentages of CD4 + CD8 + DP (near 6-fold) and CD56 -CD3 + T cells (near 3-fold) were observed compared with the control transduced culture (Fig. 2B) . In contrast, NK cell development was enhanced by overexpression of Id2, as the percentage of CD56 + CD3 -NK cells increased by 45-fold compared with the control culture (Fig. 2B) . Because Id2 can affect apoptosis of certain cell types independent of its ability to dimerize with E proteins (27) , it was important to exclude that Id2 specifically induced apoptosis in T cells. We therefore tested a mutant form of Id2 (DId2) that is unable to dimerize with E proteins, but is able to induce apoptosis (27) . Notably, DId2 did not affect lymphoid development in a FTOC (Fig. 2B) as compared with the control transduced culture reinforcing the notion that Id2 inhibits T cell development by sequestering essential E proteins. To rule out that Id2 transduced progenitor cells indirectly induced the development of NK cells, we analyzed the phenotype of the untransduced cells in the same culture. The phenotype of these untransduced cells resembled the phenotype of cells obtained in the GFP control transduced culture providing evidence that Id2 affects differentiation of the T and NK cell lineages in a cell-intrinsic manner (Supplemental Fig. 1 ).
To further confirm our results obtained in FTOC, we cocultured Id2, Id3, or control transduced thymic progenitor cells with OP9-DL1 cells in the presence of IL-7 and FLT3L. Both Id2 and Id3 The Journal of Immunologyinhibited T cell development, as we observed reduced percentages and absolute numbers of CD4 + CD8 + DP (3-to 4-fold in percentage, near 10-fold in absolute numbers, Fig. 2C, 2D ) and CD56 -CD3 + T cells (5-to 7-fold in percentage, near 10-fold in absolute numbers, Fig. 2E, 2F ) after culture compared with control transduced cells. Development of CD56 + CD3 -NK cells from Id2 and Id3 transduced thymic progenitor cells after coculture with OP9-DL1 cells, however, was hardly affected, neither in percentages nor in absolute numbers (Figs. 2E, 2F, 3) . Collectively, these data are in agreement with the results previously obtained in FTOC (15) , and support the notion that Id2 and Id3 affect human T cell development in a comparable manner.
Id2 and IL-15 synergize in NK cell development
It was unexpected that NK cell development from Id2-or Id3-transduced progenitor cells on OP9-DL1 cells was not increased, and not when analyzing the cultures over time (Fig. 2E, 2F ; data not shown). It is possible that NK cells do not survive or that development of progenitor cells is impaired in this in vitro system. Because we and others established that IL-15 plays an important role in NK cell development [ Fig. 1 (21-24) ], we assessed the effect of IL-15 on Id2 transduced thymic progenitor cells. We transduced thymic CD34 + CD1a -progenitor cells with a control-IRES-GFP or Id2-IRES-GFP construct and cultured the cells with or without IL-15 on OP9-DL1 cells. Because we wanted to minimize the effect of IL-15 in stimulating the proliferation of mature NK cells, we added a suboptimal concentration of IL-15 (0.5 ng/ ml; data not shown) in these experiments, which was 10-fold less than the lowest concentration used in the experiments described in Fig. 1B . Even this trace amount of IL-15 enhanced NK cell development from control transduced progenitor cells both in proportion and absolute numbers (Fig. 3A, 3B , Supplemental All mouse thymic NK cells expressed CD127 (IL-7Ra), and were independent of Id2 for their development (18, 34) . These data are seemingly in contrast with the role of Id2 that we observed in this study for development of thymic progenitor cells into human NK cells. In contrast to the mouse, however, we observed that the majority of human NK cells in the postnatal thymus are negative for CD127 expression (Supplemental Fig. 2) . Similarly, the Id2-transduced NK cells lacked CD127 expression, whereas T cells generated in parallel control cultures did express CD127 (Supplemental Fig. 2 ). This suggests that different pathways for thymic NK cell development exist in human and mouse.
4/4 donors
Id2 controls proliferative expansion of an IL-15 responsive CD1a
2 CD5 + progenitor pool
The observation that low concentrations of IL-15 induced a robust increase in NK cell numbers from Id2-transduced progenitor cells (Fig. 3) (Fig. 4B, Supplemental Fig. 3 ). As expected, CD7 was expressed on all CD34 + subsets and mature NK cells (Supplemental Fig. 3A) . Together, these results indicate that (subsets of) CD34 + thymic progenitor cells are not yet NK cell committed.
Then, we wanted to gain insight in the CD1/CD5 progenitor subsets, which lack expression of CD56/CD4/CD8, that were generated from Id2-transduced CD34 + progenitor cells in coculture with OP9-DL1 cells. This revealed that Id2 preferentially induced the development of CD1a -
CD5
+ cells both in percentage and absolute cell numbers (Fig. 4C, 4D T cell development is stimulated by HEB, but not E12, E47, or E2-2
Id proteins are the natural antagonists of E proteins (36) . Consistent with the blocking effect of Id2 and Id3 on T cell development and the stimulatory effect on NK cell development, the following can be hypothesized: either the levels of E protein expression are lower in NK cells compared with T cells or the E protein levels are constant, but their function is impaired in NK cells by elevated levels Id protein. In addition, elevating the levels of E protein expression in thymic progenitor cells might have a positive effect on T cell development, but not on NK cell development. To address these issues, we first analyzed E protein expression in freshly isolated thymic NK cells and their progenitor cells. In line with our hypothesis, we observed that NK cells expressed lower levels of all E protein transcripts, E12, E47, HEB, and E2-2, as compared with the levels in CD34 + CD1a 2 T/NK progenitor cells (Fig. 5A) . Further, we evaluated the contribution of the different E proteins to human thymic development. Knock-out studies in mice have implicated a role for all four E proteins in T cell development (12) (13) (14) . Therefore, we transduced HEB, E47, E12, or E2-2 in CD34 + progenitor cells and cocultured these under T cell permissive conditions using OP9-DL1 cells. None of the E proteins dramatically affected the The Journal of Immunologyrelative proportions of the early T cell subsets based on expression of CD1a and CD5 as compared with control transduced cells (Fig.  5B) . However, calculating the absolute cell numbers revealed that HEB modestly stimulated T cell development as indicated by an increase in the pool of CD1a + CD5 + T cell committed cells when compared with control transduced progenitor cells (Fig. 5C ). In contrast, ectopic expression of E47, E12, or E2-2 slightly inhibited the number of developing T cells as compared with the GFP control transduced population. Analyzing later stages of T cell development revealed that HEB stimulated the generation of CD4 + CD8 + DP T cells particularly in absolute cell numbers after 21 d of culture (Fig. 5D, 5E ). Similarly, when HEB transduced thymic progenitor cells were allowed to differentiate in FTOC, T cell development was stimulated compared with control transduced cells (Supplemental Fig. 4 ). Cells transduced with a mutant form of HEB (DHEB, which lacks the DNA binding domain and as a consequence is deficient in transcription activation) resulted in similar percentages of T cell subsets compared with control FTOCs (Supplemental Fig. 4 ). This not only suggests that HEB is likely the most critical E protein that contributes to T cell development, but in addition implies that HEB may be the E protein antagonized by Id2/3 overexpression in our experiments described in our earlier report [ (15), Fig. 2 ].
HEB inhibits Id2-induced expansion of NK cell progenitors
Our study shows that Id2 affected the T/NK lineage decision on one hand by stimulating the expansion of IL-15 responsive NK cell progenitors and on the other hand by inhibiting T cell development. Vice versa, we observed that HEB stimulated T cell development, whereas HEB was expressed at relatively low levels in thymic NK cells. This makes it tempting to speculate that the balance between HEB and Id2 determines the outcome of the T/NK lineage decision. To test this hypothesis, we cotransduced CD34 + CD1a
progenitors with HEB and Id2 or the appropriate control constructs. In line with our earlier observations (Fig. 2C, 2D ), the single Id2-transduced progenitor cells gave rise to an increase in the number of CD4 -CD8 -double negative cells (Fig. 6A , Supplemental Table III ; 4/4 donors) of which the vast majority were CD1a -CD5 + progenitor cells (Fig. 6B, 6C , Supplemental Table IV; 4/4 donors) as compared with the control transduced cells. In addition, HEB alone stimulated T cell development (Fig. 6 , Supplemental Tables III and IV; 4/4 donors and 3/4 donors, respectively), which confirms the results obtained in Fig. 5 . Notably, forcing both HEB and Id2 expression reduced the number of Id2-expanded CD1a -CD5 + (CD4 -CD8 -) cells to background levels (Fig. 6B, 6C , Supplemental Tables III and IV This suggests that the transcriptional inactivation of HEB through dimerization with Id2 is required for proper induction of the NK cell lineage program. HEB when overexpressed in thymic progenitor cells also inhibited the development of NK cells in FTOC supplemented with IL-15, suggesting that HEB prevents the IL-15 driven transition of progenitor cells into mature NK cell (Supplemental Fig.  4) . Furthermore, we observed that the Id2-induced block in T cell development could not be rescued by HEB overexpression (Fig. 6) , which makes it likely to assume that Id2 affects T cell development not only by inhibiting the transcriptional activity of HEB, but possibly also by repressing the function of other E proteins.
Discussion
In this study, we show that the inhibitor of DNA-binding protein, Id2, has a dualistic function in regulating human thymic T and NK cell differentiation. On one hand, Id2 impaired T cell development, which is consistent with previous observations using Id3 transductions in human progenitors (15) , and Id2 overexpression in mice both in vivo (37) and in vitro (38) . On the other hand, Id2, particularly in synergy with IL-15, increased the number of CD1a -
CD5
+ early human progenitor cells as well as mature NK cells. In agreement with these findings, NK cell development in mice deficient for Id2, IL-15, or IL-15 signaling components is impaired (16, 17, 25) . Interestingly, the Id2-induced expansion of the NK progenitor cell pool could be counteracted by cotransduction of the bHLH factor HEB. This reflects our findings that expression of HEB, but also other E proteins, is lower in mature NK cells compared with T cell progenitor cells. Finally, we show in this study for the first time by direct comparison that HEB, in contrast to E12, E47, or E2-2, has a positive effect on the development of early human T cells.
Our results indicated that Id2 promoted the expansion of an early CD1a -
+ NK cell progenitor pool in the thymus. This is in line with other reports showing that Id2 has a role in promoting cell proliferation through direct regulation of the cell cycle (39) (40) (41) . Because Id factors are known to sequester E proteins, we speculate that the Id2-induced expansion of CD1a -
+ progenitor cells is likely the result of inhibiting E protein activity. Contrary to what would be expected from our data shown in this report, thymic NK cell development was not inhibited in Id2-deficient mice (18) . Likely this may be explained by differences between mouse and human thymic NK cells. In mice all thymic NK cells expressed the IL-7Ra chain/CD127 (18, 34) , whereas, in contrast, only a minor fraction of NK cells in the human thymus expresses CD127. In line with this, we show in this study that the in vitro generated NK cells derived from Id2-transduced thymic progenitor cells and cultured in the presence of IL-15 did not express CD127. This could suggest that thymic NK cells that lack CD127 rely on Id2 for development and that the CD127-positive NK cells are a separate lineage, which develop independent of Id2. Although Id2 deficiency in mice did not abrogate thymic NK cell development, it did impair the development of mature bone marrow NK cells, which is rescued by simultaneous deletion of the E2A locus (18) . In contrast, the numbers of mature NK cells in the blood or spleen were not restored in the Id2/E2A doubledeficient mice (18) . Therefore, it was proposed that not E2A (i.e., E12 or E47), but alternative E proteins were suppressed by Id2 to allow NK cell development in the thymus. Based on our observation that HEB when overexpressed together with Id2 was able to counteract the expansion of human CD1a -
+ progenitor cells raises the possibility that downmodulation of HEB activity, but not E2A activity, by Id2 is required to permit NK cell development. Analysis of Id2/HEB double-deficient mice will be instrumental to confirm these findings in the mouse.
Previously, we reported that Id3, when overexpressed in human progenitor cells and cultured in FTOC blocked T cell development, whereas strongly stimulating that of NK cells (15) . In this study, we show that Id2 similarly affected T and NK cell development in FTOC. Using OP9-DL1 feeder cells to analyze T cell development in vitro (26, 42) , we directly compared Id2 and Id3 and showed that both inhibited T cell development to a similar extent. These findings, together with the observation that Id2 is expressed at higher levels in thymic NK cells compared with Id3, and in addition that Id3-deficient mice did not have obvious defects in lymphoid development (19) , add weight to the notion that Id2 may be more physiologically relevant as an NK cell promoting factor. Interestingly, however, Id2-transduced cells cocultured with OP9-DL1 cells hardly affected the NK cell numbers relative to control transduced cells. At first, these findings seemed to contradict the results found when Id2-or Id3-transduced progenitor cells were cultured in FTOC [ Fig. 2 (15) ]. An explanation to reconcile this discrepancy is the lack of IL-15 in the OP9 stromal cell cocultures. This is underscored by the finding that the addition of exogenous IL-15 to these cultures significantly induced the appearance of mature NK cells. Consistent with this, a crucial role for IL-15 in both human and murine NK cell development has been well documented (20) (21) (22) (23) 43) .
The exact stage in human NK cell development in which IL-15 exerts its effect has remained largely unclear. Attempts to isolate NKPs in humans on the basis of IL-15 responsiveness have been proven difficult as this approach reveals both NKPs and mature NK cells (43, 44) . Studies in mice genetically deficient for the expression of IL-15 revealed that IL-15 was required for the generation of mature NK cells, but not for the development of NKP cells (25) . In agreement, we and others showed that IL-15 was able to stimulate mature human NK cell development [this study and (21)]. In contrast, however, we observed that IL-15 in synergy with Id2 was capable of promoting the expansion of CD1a -CD5 + NKP cells. These in vitro-generated cells are phenotypically similar to CD34 + CD1a -CD5 + progenitor cells found in the thymus, and that, when isolated ex vivo, are responsive to IL-15. This, together with the observation that thymic stromal cells express IL-15 transcripts (24), underscores the notion that IL-15 may be involved in expanding human NKP cells also in vivo. Collectively, our findings impose a novel role for IL-15 in human NK cell differentiation in addition to its known role in survival and expansion of mature NK cells.
It is well accepted that engagement of IL-15 to its receptor, consisting of the common IL-2/15Rb and gc subunits in addition to a unique IL-15Ra chain, results in activation of several pathways, including the JAK/STAT pathway (45) . It was unexpected, however, to observe that not only the thymic CD34 + thymocytes are considered to be T cell committed and have largely lost the capacity to differentiate into NK cells as they have initiated rearrangement of TCR-b genes (1, 7) . In the mouse, it was shown that low doses of IL-15 stimulated T cell development, particularly the TCR-gd lineage (24) . Also in humans, we observed that IL-15 at relatively low concentrations (,10 ng/ml) favored TCR-gd + T cell development over TCR-ab + T cell development in FTOC, although absolute T cell numbers were reduced (Y. Yasuda and H. Spits, unpublished observation). These data suggest that CD34 where the CD34 + CD1a + CD5 + thymocytes reside, express IL-15. It will be of interest to investigate whether all cortical epithelial cells express IL-15 or that specific niches exist where TCR-gd lineage commitment is enforced.
Taken together, we propose a two-step model for NK cell lineage development: 1) Id2 expands the NKP pool and functionally impairs E proteins by sequestration, which results in a block in T cell development, and 2) further expansion of the NKP progenitor pool and subsequent differentiation into mature NK cells is driven by IL-15. In contrast, for T cell development to be released it is essential that Id2 levels are reduced, which then allows transcriptional activity of E proteins, in particular HEB.
